Rapid decline of residual renal function in patients on automated peritoneal dialysis.
OBJECTIVE
To determine the effect of peritoneal dialysis modalities such as nightly intermittent peritoneal dialysis (NIPD), continuous cyclic peritoneal dialysis (CCPD), and continuous ambulatory peritoneal dialysis (CAPD) on residual renal function.


METHODS
A six-month prospective, nonrandomized comparison study.


METHODS
Outpatient CAPD unit of a university hospital.


METHODS
Eighteen end-stage renal disease patients treated by peritoneal dialysis (8 by NIPD, 5 by CCPD, and 5 by CAPD).


METHODS
Samples from the total dialysate, blood, and 24-hour urine collection were obtained monthly.


METHODS
Urea, creatinine, and beta2-microglobulin concentrations were measured. Renal and peritoneal clearances of each substance and KT/V urea were calculated. Residual renal function (RRF) was estimated by renal creatinine clearance (RCcr).


RESULTS
No significant differences in age, sex, and primary renal disease among the three groups were noted. In all groups, anemic and hypertensive states were controlled identically, and mean weekly total (renal + peritoneal) KT/V urea (over 2.1/wk) and total creatinine clearance (over 60 L/wk/1.73 m2) were maintained during the whole experimental period. Starting mean RCcr was near 4.0 mL/min/1.73 m2 in all groups. Thereafter, a rapid and significant decline in RRF was demonstrated on NIPD and CCPD. The declining rates of RCcr values at 6 months after starting NIPD and CCPD were -0.29 and -0.34 mL/min/month, respectively, which were much greater than those of CAPD (+0.01 mL/min/month).


CONCLUSIONS
Because of a possibly characteristic progressive loss of RRF in automated peritoneal dialysis (APD), strict regular assessment of RRF should be performed from the start of APD.
Hiroshige
K
K
Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Japan.
Yuu
K
K
Soejima
M
M
Takasugi
M
M
Kuroiwa
A
A
D000328:Adult; D000368:Aged; D001794:Blood Pressure; D001835:Body Weight; D003404:Creatinine / Q000378:metabolism; D015314:Dialysis Solutions; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011446:Prospective Studies; D014508:Urea / Q000378:metabolism; D001613:beta 2-Microglobulin / Q000378:metabolism
D015314:Dialysis Solutions; D006454:Hemoglobins; D001613:beta 2-Microglobulin; D014508:Urea; D003404:Creatinine